Pfizer, Inc.

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse Other stock markets 16:01:27 2024-07-05 EDT			5-day change	1st Jan Change
28.05 ^USD	+1.26%		+0.25%	-2.57%

07-05	Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code	MT
07-05	UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches	MT

Canada Pm Trudeau Says He Talked To Global Ceo Of Pfizer About Covid-19 Vaccine Shortage, Received Assurances Firm Will Provide Canada With 4 Million Doses On Schedule By End-March

January 22, 2021 at 11:37 am

CANADA PM TRUDEAU SAYS HE TALKED TO GLOBAL CEO OF PFIZER ABOUT COVID-19 VACCINE SHORTAGE, RECEIVED ASSURANCES FIRM WILL PROVIDE CANADA WITH 4 MILLION DOSES ON SCHEDULE BY END-MARCH

Latest news about Pfizer, Inc.

Novo Nordisk Reprimanded in UK Over Undisclosed Payments; Novartis, Pfizer Found in Breach of Industry Code	07-05	MT
UK Pharmaceutical Trade Group Slams Novartis, Three Others for Breaches	07-05	MT
Pfizer: former State Street CEO joins board	07-05	CF
GlaxoSmithkline Pharmaceuticals Limited Announces Change in Management	07-05	CI
PFIZER INC : Berenberg gives a Neutral rating	07-03	ZD
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits	07-03	MT
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount	07-02	MT
Moderna, Pfizer-BioNTech COVID-19 Vaccine Patent Legal Battle Gets Mixed UK Ruling	07-02	MT
Pfizer-BioNTech, Moderna Set to Appeal Mixed UK Ruling in COVID-19 Vaccine Patent Case	07-02	MT
Pfizer: new member elected to the Board of Directors	07-02	CF
Vaxcyte Appoints John Furey to Board of Directors	07-02	CI
US DOJ informs Viatris' Mylan is no longer part of antitrust investigation	07-02	RE
Delaware Judge Rejects Drugmakers' Appeal to End Zantac Lawsuits	07-02	MT
UK court gives mixed ruling in Pfizer v Moderna COVID vaccine patents case	07-02	RE
Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge	07-01	RE
Vera Therapeutics Appoints David Johnson as Chief Operating Officer	07-01	MT
Pfizer Inc Appoints Cyrus Taraporevala to Board of Directors, Audit Committee and Compensation Committee	07-01	CI
Tiny Chain Bridge is top banker to Trump, Republican campaigns	07-01	RE
Pfizer Inc.(NYSE:PFE) added to Russell 1000 Dynamic Index	06-30	CI
Pfizer: CHMP recommends new Covid vaccine	06-28	CF
Would you like some more inflation?	06-28
EMA Says CHMP Gave Positive Opinion For mResvia RSV mRNA Vaccine For Prevention In Adults 60 Years And Older	06-28	RE
Pfizer Inc. and BioNTech SE Receives Positive CHMP Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in the European Union	06-28	CI
Pfizer Inc.(NYSE:PFE) dropped from Russell Top 50 Index	06-27	CI
Pfizer, BioNTech Get Positive Committee Opinion for Omicron JN.1-Adapted COVID-19 Vaccine in European Union	06-27	MT

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).

Sector

Pharmaceuticals

Calendar

2024-07-25 - Détachement de

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

Pfizer, Inc: A cycle for nothing?

December 14, 2023 at 10:58 am

Albert Bourla, Pfizer CEO (full interview): mRNA, acquisitions, weight-loss drugs

October 31, 2023 at 04:50 pm

More Strategies

Ratings for Pfizer, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

28.05 USD

Average target price

31.92 USD

Spread / Average Target

+13.78%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

	1st Jan change	Capi.
PFIZER, INC.	-2.57%	159B
ELI LILLY AND COMPANY	+56.89%	823B
NOVO NORDISK A/S	+39.52%	627B
JOHNSON & JOHNSON	-6.55%	353B
MERCK & CO., INC.	+15.99%	320B
ABBVIE INC.	+7.92%	295B
ASTRAZENECA PLC	+13.74%	239B
NOVARTIS AG	+13.83%	220B
ROCHE HOLDING AG	-0.49%	219B
AMGEN INC.	+7.94%	167B

Other Pharmaceuticals

Pfizer, Inc.

Equities

PFE

US7170811035

Pharmaceuticals

Canada Pm Trudeau Says He Talked To Global Ceo Of Pfizer About Covid-19 Vaccine Shortage, Received Assurances Firm Will Provide Canada With 4 Million Doses On Schedule By End-March

Latest news about Pfizer, Inc.

Chart Pfizer, Inc.

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Pfizer, Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Pharmaceuticals